Literature DB >> 15304120

Genetic polymorphisms of bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese patients with Crigler-Najjar syndrome or Gilbert's syndrome as well as in healthy Japanese subjects.

Keisuke Takeuchi1, Yoshinao Kobayashi, Shigenori Tamaki, Tomoaki Ishihara, Yoshihiro Maruo, Jun Araki, Rumi Mifuji, Toshio Itani, Makoto Kuroda, Hiroshi Sato, Masahiko Kaito, Yukihiko Adachi.   

Abstract

BACKGROUND AND AIM: Numerous mutations of bilirubin uridine diphosphate-glucuronosyltransferase gene (UGT1A1) have been reported in patients with familial unconjugated hyperbilirubinemia. The UGT1A1 mutation appears to be considerably different among ethnic groups. To clarify the incidence of this gene mutation in the Japanese population, the presence of UGT1A1 mutation was investigated in a group of Japanese patients with Crigler-Najjar syndrome type 2 (CNS2) and Gilbert's syndrome (GS), as well as in healthy anicteric subjects.
METHODS: Four patients with CNS2, 63 patients with GS, and 71 healthy subjects were enrolled in the study. The promoter and coding regions of UGT1A1 were amplified by polymerase chain reaction (PCR) from genomic DNA isolated from leukocytes. The PCR products were directly sequenced by a dye terminating method. The UGT1A1 enzyme activity was determined in COS7 cells transfected with wild or P364L (1091 C > T) mutant DNA.
RESULTS: Homozygous Y486D was observed in all four patients with CNS2. The GS patients had UGT1A1 mutations with 13 different genotypes in the promoter and coding region. Homozygous TA insertion in the TATA box (TA7) of the promoter region (TA7/7; 33%), homozygous G71R (9%), and combination of TA7/6 and heterozygous G71R (17%) were the most frequent findings in GS patients. Homozygous or heterozygous Y486D (8%) and P229Q (8%) were also observed in GS. A novel mutation, heterozygous P364L, was also identified in a GS patient. In addition to GS patients, homozygous or heterozygous TA7, G71R, and heterozygous Y486D were also observed in healthy subjects. The allele frequency of G71R and TA7 was 0.183 and 0.113 in healthy subjects, respectively. The P364L UGT1A1 enzyme activity was 64.4% lower than the wild-type enzyme activity.
CONCLUSIONS: Polymorphisms in the coding region of UGT1A1 were commonly observed in Japanese patients with GS and in healthy subjects. The genetic basis of hyperbilirubinemia appears to be different between the Japanese and Caucasian populations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15304120     DOI: 10.1111/j.1440-1746.2004.03370.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  21 in total

1.  Incidence of atazanavir-associated hyperbilirubinemia in Korean HIV patients: 30 months follow-up results in a population with low UDP-glucuronosyltransferase1A1*28 allele frequency.

Authors:  Pyoeng Gyun Choe; Wan Beom Park; Jin Su Song; Nak-Hyun Kim; Kyoung-Ho Song; Sang Won Park; Hong Bin Kim; Nam Joong Kim; Myoung-don Oh
Journal:  J Korean Med Sci       Date:  2010-09-17       Impact factor: 2.153

2.  Gilbert's syndrome: High frequency of the (TA)7 TAA allele in India and its interaction with a novel CAT insertion in promoter of the gene for bilirubin UDP-glucuronosyltransferase 1 gene.

Authors:  Shabana Farheen; Sanghamitra Sengupta; Amal Santra; Suparna Pal; Gopal Krishna Dhali; Meenakshi Chakravorty; Partha P Majumder; Abhijit Chowdhury
Journal:  World J Gastroenterol       Date:  2006-04-14       Impact factor: 5.742

3.  Contribution of G71R mutation to Gilbert's syndrome phenotype in a Greek patient: A case report.

Authors:  Vassiliki Kalotychou; Maria Karakosta; Revekka Tzanetea; Aleka Stamoulakatou; Kostas Konstantopoulos; Yannis Rombos
Journal:  World J Gastrointest Pharmacol Ther       Date:  2011-10-06

Review 4.  New insights in bilirubin metabolism and their clinical implications.

Authors:  Eva Sticova; Milan Jirsa
Journal:  World J Gastroenterol       Date:  2013-10-14       Impact factor: 5.742

5.  Pharmacogenetics of irinotecan: An ethnicity-based prediction of irinotecan adverse events.

Authors:  Shouji Shimoyama
Journal:  World J Gastrointest Surg       Date:  2010-01-27

6.  Influence of UGT1A1 polymorphism on etoposide plus platinum-induced neutropenia in Japanese patients with small-cell lung cancer.

Authors:  Yutaka Negoro; Ryoichi Yano; Mari Yoshimura; Yoko Suehiro; Shinji Yamashita; Takaaki Kodawara; Kyohei Watanabe; Hitoshi Tsukamoto; Toshiaki Nakamura; Maiko Kadowaki; Miwa Morikawa; Yukihiro Umeda; Masaki Anzai; Tamotsu Ishizuka; Nobuyuki Goto
Journal:  Int J Clin Oncol       Date:  2018-10-17       Impact factor: 3.402

7.  Changes in the liver function tests during the attacks of familial Mediterranean fever.

Authors:  Cengiz Korkmaz; Timuçin Kaşifoğlu
Journal:  Rheumatol Int       Date:  2006-09-28       Impact factor: 2.631

8.  Bilirubin glucuronidation revisited: proper assay conditions to estimate enzyme kinetics with recombinant UGT1A1.

Authors:  Jin Zhou; Timothy S Tracy; Rory P Remmel
Journal:  Drug Metab Dispos       Date:  2010-07-28       Impact factor: 3.922

Review 9.  The clinical application of UGT1A1 pharmacogenetic testing: gene-environment interactions.

Authors:  Sara Correia Marques; Ogechi N Ikediobi
Journal:  Hum Genomics       Date:  2010-04       Impact factor: 4.639

10.  Genetic testing of UGT1A1 in the diagnosis of Gilbert syndrome: The discovery of seven novel variants in the Chinese population.

Authors:  Leilei Gu; Yue Han; Donghua Zhang; Qiming Gong; Xinxin Zhang
Journal:  Mol Genet Genomic Med       Date:  2022-04-14       Impact factor: 2.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.